A styrofoam container (a) consisting of two moulded pieces of styrofoam held together by the label; inside are five cylindrical glass ampoules (b-f) with icicle-shaped melted glass seals containing the vaccine and one glass vial (g) stopped with a rubber stopper and sealed with a metal ring around …
A styrofoam container (a) consisting of two moulded pieces of styrofoam held together by the label; inside are five cylindrical glass ampoules (b-f) with icicle-shaped melted glass seals containing the vaccine and one glass vial (g) stopped with a rubber stopper and sealed with a metal ring around the lip containing a diluent.
Number Of Parts
7
Part Names
a - box - Size: Length 13.9 cm x Width 8.3 cm x Depth 3.0 cm
b-f - ampoule - Size: Length 5.8 cm x Diam. 1.1 cm
(a) Top: "5 DOSES Bio. 49 // MEASLES VIRUS VACCINE, // LIVE, ATTENUATED // C // Contains 5 one-dose ampoules of attenuated Edmonston strain vaccine grown on // tissue cultures of canine renal cells and one 4.5 cc. vial of diluent for preparing solu- // tion for injection. Diluent contains 0.05% methylparaben and 0.005% propylparaben // as preservatives. // Prepare solution for injection by slowly adding 0.7 cc. diluent to contents of // ampoule. Gently agitate and allow a few seconds for the contents to dissolve. // DOSE – A single injection of 0.5 cc. of solution prepared as above, administered // subcutaneously into the upper arm; or subcutaneously or intramuscularly into the // upper, outer quadrant of the buttocks. For coadministration of gamma globulin, // see package insert. // Administration to infants under nine months of age is not recommended. // See package insert for contraindications and precautions. // Expiration Date: [printed] // Oct. 15, 1969 [stamped] // Lot No. [printed] // PD804B [stamped] // Stock 4-49-1-70 // Distributed by // PARKE, DAVIS & CO. DETROIT, MICH., U.S.A."; front: "Each dose contains not less than 1000 TCid50 ["50" subscr.] of measles virus vaccine as compared // to U.S. NIH measles virus reference standard, not more than 33 mcg. dihydrostrep- // tomycin sulfate and 17 units of polymyxin B sulfate. // CUT ON DOTTED LINE // Store at temperature between 2° and 8° C (35.6° and 46.4° F.). // Storage at freezing temperature not required. // Protect vaccine from prolonged exposure to direct sunlight."; back: "Manufactured by // PHILIPS ROXANE, INC. ST JOSEPH, MO., U.S.A. // U.S. Licence 376. Canadian Licence 127"; (b-e) "1 DOSE Bio. 49 // MEASLES VIRUS VACCINE, // LIVE, ATTENUATED // 1000 TCID50 ["50" subscr.] // See insert. // US. Licence 376 // Mfd. by Philips Roxane, Inc. // St. Joseph, Mo., U.S.A. // Dist. by Parke, Davis & Co. // Detroit, Mich., U.S.A.// LOT PD 804B // Exp. )ct. 15-69 [stamped]"; (f) same printed text as (b-e) followed by "LOT PD619-1 // Exp. Aug. 24-68"; (g) "4.5 CC. // DILUENT FOR MEASLES VIRUS // VACCINE, LIVE, ATTENUATED // Mfd. by Philips Roxane, Inc. // St. Joseph, Mo., U.S.A. // Dist. by Parke, Davis & Co. // Detroit, Mich., U.S.A. // Contains 0.05% methylparaben and // 0.005% propylpara- // ben as preservatives. // LOT 7404D [stamped]"
Permanent Location
Storage Room 0010
0010-A3-5 Row B
Condition Remarks
Label is yellowing, dirty; some dents in styrofoam; labels on ampoules and vial are yellowing.
Copy Type
Original
Exhibit History
On exhibit at City of Ottawa - Public Health L-2016-3 14 Mar 2016 – 31 Dec 2018; extended to 31 Dec 2023
May 24 - Sept. 13, 2001: Agnes Etherington Art Centre Museopathy exhibit